Skip to main content
Have a personal or library account? Click to login
Impact of Cholecystectomy on Gastric Mucosal c-MYC and h-TERT Expression; A Potential Link to Gastric Cancer Development Cover

Impact of Cholecystectomy on Gastric Mucosal c-MYC and h-TERT Expression; A Potential Link to Gastric Cancer Development

Open Access
|May 2026

References

  1. Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M, Kavosi Z. Risk factors for gastric cancer: a systematic review. Asian Pac J Cancer Prev. 2018;19(3):591–603. doi:10.22034/APJCP.2018.19.3.591
  2. Mukkamalla SKR, Recio-Boiles A, Babiker HM. Gastric cancer. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan 15.
  3. Wu YC, Chiu CF, Hsueh CT. The role of bile acids in cellular invasiveness of gastric cancer. Cancer Cell Int. 2018;18:75. doi:10.1186/s12935-018-0569-0
  4. Kang SH, Kim YH, Roh YH, et al. Gallstone, cholecystectomy and risk of gastric cancer. Ann Hepatobiliary Pancreat Surg. 2017;21(3):131–137. doi:10.14701/ahbps.2017.21.3.131
  5. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res. 2005;589(1):47–65.
  6. Wang X, Zhou P, Sun X, et al. Acidified bile acids increase hTERT expression via c-myc activation in human gastric cancer cells. Oncol Rep. 2015;33(6):3038–3044. doi:10.3892/or.2015.3908
  7. Kim W, Ludlow AT, Min J, et al. Regulation of the human telomerase gene TERT by telomere position effect—over long distances (TPE-OLD): implications for aging and cancer. PLoS Biol. 2016;14(12):e2000016.
  8. Takeno S, Hashimoto T, Maki K, et al. Gastric cancer arising from the remnant stomach after distal gastrectomy: a review. World J Gastroenterol. 2014;20(38):13734–13740. doi:10.3748/wjg.v20.i38.13734
  9. Kapoor T, Wrenn SM, Callas PW, Abu-Jaish W. Cost analysis and supply utilization of laparoscopic cholecystectomy. Minim Invasive Surg. 2018;2018:7838103. doi:10.1155/2018/7838103
  10. Yang Y, Liu MH, Li Y. Association between cholecystectomy and gastric cancer risk: a systematic review and meta-analysis. Front Oncol. 2022;12:667736. doi:10.3389/fonc.2022.667736
  11. Kellosalo J, Alavaikko M, Laitinen S. Effect of biliary tract procedures on duodenogastric reflux and the gastric mucosa. Scand J Gastroenterol. 1991;26(12):1272–1278. doi:10.3109/00365529108998624
  12. Aydin S, Akin ML, Karakaya M, et al. Alkalen reflü gastrit ve tani problemleri. Çağdaş Cerrahi Dergisi. 1997;11:36–39.
  13. Keane FB, Dimagno EP, Malagelada JR. Duodeno-gastric reflux in humans: its relationship to fasting antroduodenal motility and gastric, pancreatic, and biliary secretion. Gastroenterology. 1981;81(4):726–731.
  14. Tatsugami M, Ito M, Tanaka S, et al. Bile acid promotes intestinal metaplasia and gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2012;21(11):2101–2107. doi:10.1158/1055-9965. EPI-12-0730
  15. Sue S, Shibata W, Maeda S. Helicobacter pylori-induced signaling pathways contribute to intestinal metaplasia and gastric carcinogenesis. Biomed Res Int. 2015;2015:737621. doi:10.1155/2015/737621
  16. Fall K, Ye W, Nyrén O. Risk for gastric cancer after cholecystectomy. Am J Gastroenterol. 2007;102(6):1180–1184. doi:10.1111/j.1572-0241.2007.01169.x
  17. Kang SH, Kim YH, Roh YH, et al. Gallstone, cholecystectomy and risk of gastric cancer. Ann Hepatobiliary Pancreat Surg. 2017;21(3):131–137. doi:10.14701/ahbps.2017.21.3.131
  18. Schmidt JC, Cech TR. Human telomerase: biogenesis, trafficking, recruitment, and activation. Genes Dev. 2015;29(11):1095–1105.
  19. Bell RJ, Rube HT, Xavier-Magalhães A, Costa BM, Mancini A, Song JS, et al. Understanding TERT promoter mutations: a common path to immortality. Mol Cancer Res. 2016;14(4):315–23.
  20. Borah S, Xi L, Zaug AJ, Powell NM, Dancik GM, Cohen SB, et al. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science. 2015;347(6225):1006–10.
  21. Heidenreich B, Rachakonda PS, Hosen I, Volz F, Hemminki K, Weyerbrock A, et al. TERT promoter mutations and telomere length in adult malignant gliomas and recurrences. Oncotarget. 2015;6(12):10617–33.
  22. Vinagre J, Almeida A, Pópulo H, Batista R, Lyra J, Pinto V, et al. Frequency of TERT promoter mutations in human cancers. Nat Commun. 2013;4:2185.
  23. Carino A, Graziosi L, D’Amore C, Cipriani S, Marchianò S, Marino E, et al. The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines. Oncotarget. 2016;7(38):61021–35. doi: 10.18632/oncotarget.10477
  24. Sun M, Ma T, Yuan H. Association between history of cholecystectomy and risk of gastric cancer: a meta-analysis of epidemiological studies. BMJ Open. 2023;13(8):e057138. doi: 10.1136/bmjopen-2021-057138 PMID: 37640459
  25. Coats M, Shimi SM. Cholecystectomy and the risk of alimentary tract cancers: a systematic review. World J Gastroenterol. 2015;21(12):3679–93. doi: 10.3748/wjg.v21.i12.3679 PMID: 25834337
  26. 26. Tang B, Xie R, Qin Y, Xiao YF, Zheng L, Dong H, et al. Human telomerase reverse transcriptase (hTERT) promotes gastric cancer invasion through cooperating with c-Myc to upregulate heparanase expression. Oncotarget. 2016;7(10):11364–79. doi: 10.18632/oncotarget.6575 doi: 10.18632/oncotarget.6575
    TangB XieR QinY XiaoYF ZhengL DongH Human telomerase reverse transcriptase (hTERT) promotes gastric cancer invasion through cooperating with c-Myc to upregulate heparanase expression Oncotarget 2016 7 1011364 79 10.18632/oncotarget.6575 doi: 10.18632/oncotarget.6575
  27. de Souza CRT, Leal MF, Calcagno DQ, Sozinho EKC, Borges BDN, Montenegro RC, et al. MYC deregulation in gastric cancer and its clinicopathological implications. PLoS One. 2013;8(5):e64420. doi: 10.1371/journal.pone.0064420
  28. Zhang E, Han L, Yin D, Kong R, De W, Chen J. c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol. 2014;31(5):914. doi: 10.1007/s12032-014-0914-7
  29. Gladych M, Wojtyla A, Rubis B. Human telomerase gene expression and activity: from the molecules to the clinics. Int J Mol Sci. 2021; 22(9): 4615
  30. Geng F, Wenzel S, Tansey WP. Haploinsufficiency of the Myc regulator Mad1 promotes cell proliferation and transformation. Proc Natl Acad Sci U S A. 2017; 114(40): 10666–10671
  31. Kyo S, Takakura M, Taira T, et al. Sp1 and c-Myc participate in auto-regulation of telomerase substitution in human cancer cells. Nucleic Acids Res. 2000; 28(3): 669–677
  32. Stahl P, Seeschaaf C, Lebok P, Kutup A, Bockhorn M, Izbicki JR, et al. Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer. BMC Gastroenterol. 2015;15:7. doi: 10.1186/s12876-015-0231-4
  33. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307–19. doi:10.1016/j.cell.2013.03.035
  34. Tselepis C, Morris CD, Wakelin D, Hardy R, Perry I, Luong QT, et al. Upregulation of the oncogene c-myc in Barrett’s adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut. 2003;52(2):174–80. doi: 10.1136/gut.52.2.174
  35. Wang X, Sun L, Wang X, Kang H, Ma X, Wang M, et al. Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c-Myc expression. Cancer Med. 2017;6(4):788–97. doi: 10.1002/cam4.999
  36. Goldman A, Chen HD, Roesly HB, Hill KA, Tome ME, Dvorak B, et al. Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett’s esophagus pathogenesis. Am J Physiol Gastrointest Liver Physiol. 2011;300:G292–302. doi: 10.1152/ajpgi.00461.2010
  37. Debruyne PR, Bruyneel EA, Li X, Zimber A, Gespach C, Mareel MM. The role of bile acids in carcinogenesis. Mutat Res. 2001;480–481:359–69. doi: 10.1016/s0027-5107(01)00195-6
  38. 38. Silva TC, Leal MF, Calcagno DQ, de Souza CR, Khayat AS, dos Santos NP, et al. hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions. BMC Gastroenterol. 2012;12:85. doi:10.1186/1471-230X-12-85
    SilvaTC LealMF CalcagnoDQ de SouzaCR KhayatAS dos SantosNP hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions BMC Gastroenterol 2012 12 85 10.1186/1471-230X-12-85
Language: English
Page range: 57 - 64
Published on: May 14, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2026 E Kasap, S Sabah Özcan, L Elmas, F Seher Ozalp Ates, M Korkmaz, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.